期刊文献+

溃愈散灌肠联合高压氧治疗溃疡性结肠炎疗效观察 被引量:1

Effectiveness of traditional Chinese medicine Kuiyusan combined with hyperbaric oxygen in treatment of ulcerative colitis
原文传递
导出
摘要 [目的]观察中药溃愈散灌肠联合高压氧治疗溃疡性结肠炎(UC)的疗效,探讨治疗UC安全有效的方法。[方法]120例UC患者随机分为治疗组(溃愈散联合高压氧治疗)、中药(灌肠散)对照组、西药对照组,疗程均为30d,观察治疗效果、临床症状控制及3个月后复发情况。[结果]治疗组有效率100.0%,明显高于中药对照组(85.0%)和西药对照组(65.0%),各组比较差异有统计学意义(P<0.05),治疗组治疗后复发率较西药对照组明显减少(P<0.05)。[结论]溃愈散灌肠治疗UC具有良好的效果,联合高压氧治疗可以提高其疗效,且安全有效。 [Objective]To observe the effect of Chinese medicine Kuiyusan combined with hyperbaric oxygen in the treatment of ulcerative colitis (UC) ,and to explore a safe and effective method for treating ulcerative colitis. [Methods]One hundred and twenty cases of UC patients were randomly divided into the treatment group (Chinese medicine combined with hyperbaric oxygen therapy), Chinese medicine group, and western medicine group. Each group was treated for 30 days. The therapeutic effect,clinical symptoms and recurrence after 3 months were observed. [Results]The effective rate was 100%, 85. 0%, and 65.0% respectively in treatment group, Chinese medicine group, and western medicine group. The differences among three groups were statistically significant (P〈0. 05). The recurrence rate was remarkably lower in the treatment group than in the control groups (P〈0.05). [Conelusion]Kuiyusan has good effects on UC. Combined with hyperbaric oxygen, the therapeutic effects can be enhanced with good safety.
出处 《中国中西医结合消化杂志》 CAS 2013年第9期453-455,共3页 Chinese Journal of Integrated Traditional and Western Medicine on Digestion
基金 青岛市公共领域科技支撑计划(09-1-1-45-nsh)
关键词 结肠炎 溃疡性 溃愈散 高压氧 ulcerative colitis Kuiyusan hyperbaric oxygen
  • 相关文献

参考文献4

二级参考文献32

  • 1冯百岁,刘占举,牛正先.美沙拉秦治疗溃疡性结肠炎的临床疗效及对血清TNF-α和IL-8的影响[J].郑州大学学报(医学版),2006,41(5):830-833. 被引量:40
  • 2潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247.
  • 3潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154.
  • 4Qureshi AI, Cohen RD. Mesalamine delivery systems, do they really make much difference? Adv Drug Deliv Rev, 2005, 57:281-302.
  • 5Green JR, Lobo AJ, Holdsworth CD, et al. Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. The Abacus Investigator Group. Gastroenterology, 1998, 114 : 15-22.
  • 6Pruitt R, Hanson J, Safdi M,et al. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis. Am J Gastroenterol, 2002, 97:3078-3086.
  • 7Sandborn W J, Hanauer SB. Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine prodrugs used in the management of ulcerative colitis. Aliment Pharmacol Ther, 2003, 17:29-42.
  • 8Hanauer SB. Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis. Aliment Pharmacol Ther, 2006, 24 (Suppl 3) :37-40.
  • 9Friedman LS, Richter JM, Kirkham SE, et al. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial. AmJ Gastroenterol, 1986, 81:412-418.
  • 10Green JR, Mansfield JC, Gibson JA, et al. A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine. 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis. Aliment Pharmacol Ther, 2002, 16:61-68.

共引文献1496

同被引文献24

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部